9 March 2021
DEMECAN erhält Darlehen in einstelliger Millionenhöhe von der Volksbank Mittweida eG

DEMECAN – der einzige unabhängige deutsche Produzent von medizinischem Cannabis – erhält von der Volksbank Mittweida eine Fremdkapitalfinanzierung in Millionenhöhe. Das Darlehen dient der Finanzierung des im Sommer 2020 geglückten Erwerbs der Produktionsstätte für medizinisches Cannabis. […] (only german)

March 5, 2021 - Apotheke Ad-hoc
DEMECAN: Cannabis-Versorgung sichern
Go to article
3 March 2021
DEMECAN: With pioneering spirit and responsibility for patient care.

For just under four years, seriously ill patients have been able to obtain medical cannabis on prescription. Tens of thousands of patients with chronic pain, spasticity, anorexia/wasting, nausea and vomiting during chemotherapy already benefit from this additional therapy option. […]

1 February 2021
DEMECAN enters into a Medical Cannabis Supply Agreement with MediPharm Labs Australia

DEMECAN enters into a Supply-Agreement with MediPharm Labs Australia (MediPharm Labs) for the supply of multiple proprietary full-spectrum cannabis extracts. […]

January 5, 2021 - ZEIT Online
Dieses Jahr geht es los mit dem kommerziellen Anbau
Go to article
10 September 2020
Cannabis Agency visits DEMECANs production facility

Dr. Constantin von der Groeben, Managing Director and co-founder of DEMECAN: “We are delighted that the cannabis agency has visited our premisesproduction facility. […]